[{"id":"8631e131-e437-4680-b150-4e7a409ff15f","acronym":"NeoPancOne","url":"https://clinicaltrials.gov/study/NCT04472910","created_at":"2021-01-18T21:29:23.530Z","updated_at":"2024-07-02T16:35:28.019Z","phase":"","brief_title":"GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma","source_id_and_acronym":"NCT04472910 - NeoPancOne","lead_sponsor":"University Health Network, Toronto","biomarkers":" GATA6","pipe":" | ","alterations":" GATA6 expression","tags":["GATA6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GATA6 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 5-fluorouracil • irinotecan"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 84","initiation":"Initiation: 08/21/2020","start_date":" 08/21/2020","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-11-27"}]